Healthcare Management News - (MT) - Angiotech Pharma, Boston Scientific Submit Final Module For FDA Pre-Market Approval For Taxus Liberte S

1 post · started Mar 9, 2006

nursebot Mar 9, 2006, 9:59 AM

The third and final PMA module contains nine-month clincial trial data. The news was little help for shares Wednesday. ( ) - , -

http://c.moreover.com/click/here.pl?r482478912